Leo Wealth LLC’s AbbVie ABBV Stock Holding History

Leo Wealth LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.51M	Buy	16,154 +766	+5%	+$170K	0.26%	78
2025 Q4	$3.52M	Buy	15,388 +2,739	+22%	+$624K	0.26%	71
2025 Q3	$2.93M	Sell	12,649 -9,927	-44%	-$2.02M	0.38%	52
2025 Q2	$4.19M	Buy	22,576 +2,313	+11%	+$430K	0.33%	58
2025 Q1	$4.25M	Sell	20,263 -896	-4%	-$174K	0.61%	32
2024 Q4	$3.76M	Sell	21,159 -1,069	-5%	-$197K	0.34%	52
2024 Q3	$4.39M	Buy	22,228 +1,445	+7%	+$270K	0.4%	44
2024 Q2	$3.56M	Buy	20,783 +10,171	+96%	+$1.68M	0.36%	49
2024 Q1	$1.93M	Sell	10,612 -7,728	-42%	-$1.33M	0.2%	88
2023 Q4	$2.92M	Buy	+18,340	New	+$2.67M	0.3%	57

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Leo Wealth LLC's ABBV Position: Q1 2026 in Review

Leo Wealth LLC increased its AbbVie (ABBV) stake by 5% in Q1 2026, buying an estimated $170K and bringing the position to 16,154 shares worth $3.51M. The position accounts for 0.26% of the portfolio, ranked #78.

Leo Wealth LLC first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.39M in Q3 2024. 4,082 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Leo Wealth LLC held 16,154 shares of AbbVie worth $3.51M as of Q1 2026.
Leo Wealth LLC bought 766 AbbVie shares in Q1 2026, an estimated $170K.
AbbVie made up 0.26% of Leo Wealth LLC's portfolio in Q1 2026, its #78 holding.
Leo Wealth LLC first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Leo Wealth LLC's AbbVie position peaked at $4.39M in Q3 2024.
4,082 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.